Trial reportFrontiers in neurology2025
The impact of moxibustion on brain function in vascular dementia: a neuroimaging study involving amplitude of low-frequency fluctuations and functional connectivity.
Trial report in Frontiers in neurology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Object: On the basis of determining the clinical effect of moxibustion on vascular dementia (VD), this study explored the central mechanism of moxibustion on VD through fMRI. Method: Fifty-five VD patients formed the observation group (treated with moxibustion at GV20, GV14, and GV24; 20 min/acupoint, once every other day, three times a week) and 50 healthy individuals served as the control group. The Montreal Cognitive Assessment (MoCA) and Mini-Mental State Examination (MMSE) were administered, and fMRI data collected, pre- and post-treatment for the observation group, and once for the control group. Amplitude of low-frequency fluctuation (ALFF) was analyzed for pre-treatment fMRI data of both groups. Regions of interest (ROI) were defined by discrepant brain regions, and functional connectivity (FC) was analyzed for the observation group. Result: After moxibustion treatment, MoCA scores increased with a mean difference (MD) of 2.0385 (95% CI, 1.6867 to 2.3902), and MMSE scores with an MD of 3.3077 (95% CI, 2.7997 to 3.8156), both significantly ( Discussion: Moxibustion can effectively improve the cognitive dysfunction in VD patients, possibly by promoting DMN functional recovery and facilitating functional reorganization.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.